WHO halts malaria drug in COVID-19 trials

The World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with COVID-19 after they failed to reduce mortality. This report produced by Jillian Kitchener.

Multimedia

Most Popular Videos